✦ LIBER ✦

569 Dose optimization and safety of the therapeutic hepatitis C virus (HCV) peptide vaccine IC41 in healthy subjects

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of a novel the

✍ Christa Firbas; Bernd Jilma; Erich Tauber; Vera Buerger; Sandra Jelovcan; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Safety, tolerability and immunogenicity

✍ Gaggar, Anuj; Coeshott, Claire; Apelian, David; Rodell, Timothy; Armstrong, Bria 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 725 KB

Safety and tolerability of chikungunya v

✍ Chang, Lee-Jah; Dowd, Kimberly A; Mendoza, Floreliz H; Saunders, Jamie G; Sitar, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 254 KB

Safety and immunogenicity of concomitant

✍ A. Kaltenböck; K. Dubischar-Kastner; G. Eder; W. Jilg; C. Klade; H. Kollaritsch; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Safety and efficacy of an induction dose

✍ C. Tural; R. Solà; R. Rubio; M. Santín; R. Planas; C. Quereda; J. Berenguer; M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB